Dr. Hill is the Director of the Lymphoid Malignancies Program at the Cleveland Clinic Taussig Cancer Institute. He received his medical degree from the University of Chicago Pritzker School of Medicine, where he also completed his residency in Internal Medicine. He conducted his hematology/oncology fellowship at the Cleveland Clinic. His clinical and research focus is in chronic lymphocytic leukemia (CLL) and lymphoma. He is the principal investigator of multiple ongoing clinical trials of new cancer treatments, including novel cellular therapies. He served as the Chairman of the Pharmacy & Therapeutics (P&T) Committee within the Department of Hematology and Medical Oncology for 10 years and has been on the editorial board of several peer-reviewed journals. He is Associate Professor of Medicine at the Cleveland Clinic Lerner College of Medicine, a prior committee member of the National Comprehensive Cancer Network (NCCN), and an active member of the Case Comprehensive Cancer Center, American Society of Hematology (ASH), the Center for International Blood and Marrow Transplant Research (CIBMTR), and the Eastern Oncology Group (ECOG) lymphoma committee.